Skip to content
Moojaz — موجز
Search
Menu
HomeRegionsMaghrebAfricaMiddle EastEuropeAsiaAmericasWorldSectionsPoliticsEconomySecurityHealthScienceTechnologyAIEnvironmentCultureSportsSearch
Morocco
File

Sothema’s planned acquisition of Ramo Pharm

This dossier follows Sothema’s agreement to acquire Ramo Pharm, its regulatory review and documented completion milestones. It distinguishes signing an agreement from taking effective control.

Last updated : 1 key moments
Vitamin D2 tablets in an illustrative photograph.
Vitamin D2 supplements photographed in April 2019. Generic illustration, not identified as a Ramo Pharm brand. Mx. Granger, CC0. — Mx. Granger / Wikimedia Commons — CC0 1.0 https://creativecommons.org/publicdomain/zero/1.0/ — compléments de vitamine D2, 20 avril 2019, recadrage existant, sans nouvelle modification.

Where things stand

On 28 October 2026, Sothema announced an agreement to acquire 100% of Ramo Pharm. Completion remains conditional, including on approval from the Competition Council.

Reported information

Sothema announces conditional agreement to acquire Ramo Pharm

Sothema announced an agreement on 28 October 2026 to acquire 100% of Ramo Pharm, a Moroccan dietary supplements company. Completion remains subject, among other conditions, to approval from the Competition Council.

Vitamin D2 tablets in an illustrative photograph.
Vitamin D2 supplements photographed in April 2019. Generic illustration, not identified as a Ramo Pharm brand. Mx. Granger, CC0. — Mx. Granger / Wikimedia Commons — CC0 1.0 https://creativecommons.org/publicdomain/zero/1.0/ — compléments de vitamine D2, 20 avril 2019, recadrage existant, sans nouvelle modification.

The group intends to make the transaction the foundation of a wellness and consumer health business alongside general medicine, specialised products and dialysis. It plans to use its distribution networks to develop Ramo Pharm’s brands in Morocco and internationally.

The announcement concerns a signed agreement and does not establish that control has already transferred. According to Le Desk, neither the purchase price nor the completion timetable has been disclosed. Growth and operating synergies remain Sothema’s objectives.

Sources 3